‘Obesity paradox’ refuted

Mortality is not lower among adults with diabetes who were overweight or obese at diagnosis than among those who were of normal weight, as has been suggested by proponents of the "obesity...

Field of Interest: Endocrinology
Type: News Item

FDA approves dapagliflozin for type 2 diabetes

Dapagliflozin, a sodium-glucose cotransporter 2 inhibitor, has been approved for the treatment of type 2 diabetes with a requirement that the manufacturer conduct postmarketing studies that address...

Field of Interest: Endocrinology
Type: News Item

‘JNC 8’ guideline follows convoluted endgame

UPDATED Jan. 4, 2014 The federally funded program to produce a set of U.S. guidelines for hypertension management, a process more than 5 years in the making, came to an unusual end on...

Field of Interest: Cardiology
Type: News Item

Genotyping adds little to optimized warfarin dosing

DALLAS – Genotyping to guide the starting dosage of warfarin treatment showed no added value above tailoring treatment with a panel of clinical features in a randomized, controlled U.S. trial of more...

Field of Interest: Cardiology
Type: News Item

Low-FODMAP diet reduced IBS symptoms

Diets low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols reduced functional gastrointestinal symptoms in patients with irritable bowel syndrome. The finding, published...

Field of Interest: Gastroentero...
Type: News Item

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.